Document:

Exhibit 10.1

EXECUTION VERSION

 

SEPARATION AGREEMENT AND RELEASE

 

This Separation Agreement
and Release (“Agreement”) is made and entered into as of March 17, 2014 by and between David Levin (“Levin”)
and Trade Street Residential, Inc., a Maryland corporation, including its affiliates, parent entities and subsidiaries (“Company”).
For purposes hereof, Levin and Company shall be collectively referred to herein as the "Parties," and individually,
as a "Party."

 

WHEREAS, Company
has employed Levin as its President and Vice Chairman in accordance with that certain Employment Agreement dated September 26,
2013, by and between the Company and the Levin (“Employment Agreement”);

 

WHEREAS, Levin
currently serves as a member of the Board of Directors of the Company (the “Board”); and

 

WHEREAS, Levin
and the Company have reached the agreement set forth herein regarding the terms of Levin’s departure from his employment
with the Company, his resignation as a member of the Board and the termination of his Employment Agreement;

 

NOW, THEREFORE,
in consideration of the mutual covenants set forth herein, and other good and valuable consideration, the receipt and adequacy
of which are hereby acknowledged, Levin and Company, hereby intending to be legally bound, agree as follows:

 

1.                 
Recitals. The recitals set forth above are true and correct and are incorporated herein by reference.

 

2.                 
Separation Date. Levin’s separation from the Company shall be effective as of 4:00 P.M. Eastern Standard Time
on March 18, 2014 (the “Separation Date”). Effective on the Separation Date, Levin will be deemed to
have (i) resigned as a member and the Vice Chairman of the Board, (ii) resigned his position as President of the Company and (iii)
terminated all other employee, agency, lessor, sublessor, licensor, sublicensor and other vendor relationships with the Company.
Levin warrants and represents that he has returned, or will promptly hereafter return, to the Company all property of the Company
in his possession, custody, or control, including, but not limited to, files (paper and electronic) and other documents, client
records, working papers, reports, computers and other hardware or software, access cards, office keys, and all other Company property
of any nature.

 

3.                 
Release.

 

(a) In consideration
of the payments and other benefits to be provided by the Company to Levin after the Separation Date, Levin, for himself and his
heirs, executors, administrators, affiliates, personal representatives and assigns, hereby irrevocably and unconditionally forever
releases and discharges Company, its past and present shareholders, officers, directors, partners, managers, members, consultants,
agents, employees, subsidiaries, parent corporations, affiliated or related entities and its or their past and present shareholders,
officers, directors, agents, attorneys, employees and all of the successors, assigns, and legal representatives of the foregoing
(collectively, “Releasees”) of and from, any matter or thing occurring in whole or in part through the
date hereof, any and all rights, claims, grievances, arbitrations, liabilities or causes of action (“Claims”)
which Levin has asserted, could assert or which could be asserted on his behalf (1) arising from Levin’s relationship to,
employment with or service as an employee, officer, director, or manager of the Company or its subsidiaries and affiliates prior
to the date of execution and delivery of this Agreement, including his separation from such employment; provided, however, that
Levin does not release or discharge any claim that Levin may have for or in respect of indemnification or advancement of expenses
pursuant to any indemnification agreement between Levin and the Company or pursuant to the Company’s organizational documents
or applicable state law, or (2) arising under the Age Discrimination in Employment Act of 1967, as amended (the “ADEA”),
the Family and Medical Leave Act of 1993, the Employee Retirement Income Security Act of 1974, Title VII of the Civil Rights Act
of 1964, the Rehabilitation Act of 1973, the Equal Pay Act, the Lilly Ledbetter Fair Pay Act of 2009, the Civil Rights Act of 1866,
the Civil Rights Act of 1991, the Americans with Disabilities Act of 1990, the ADA Amendments Act of 2008, the Genetic Information
Nondiscrimination Act, the Florida Human Rights Act of 1977, the Florida Civil Rights Act of 1992, Section 760.50 of the Florida
Statutes, the Miami-Dade County Code, and the wage and discrimination laws of the United States or any State of the United States
or any other country and their subdivisions, including any state or local law, ordinance, regulation or rule, all of the foregoing
as heretofore or hereafter amended, or any court decree, heretofore or hereafter promulgated. To the extent permitted by law, Levin
also waives any and all rights under the laws of any jurisdiction in the United States that would limit the foregoing release and
waiver of which he had knowledge as of the date hereof. Levin recognizes that, among other things, he is releasing Releasees of
and from any and all claims he might have against Releasees for retaliation of any kind, pain and suffering, emotional distress,
defamation, libel, slander and for discrimination based on age, gender, national origin, race, religion, disability, sexual orientation,
or veteran status. Notwithstanding any other provision of this Agreement to the contrary, this Agreement does not encompass, and
Levin does not release, waive or discharge, the obligations of the Company, or the rights of Levin, under (i) any indemnification
or similar agreement with or for the benefit of Levin (including, without limitation, under Section 11 of the Employment Agreement
or otherwise existing pursuant to the Company’s organizational document or applicable state law), or (ii) this Agreement.

 

    	 

    	 

    

 

(b) In consideration
of the benefits provided by Levin to the Company under this Agreement, the Company, on behalf of itself and its affiliates and
each of their respective officers, directors, partners, shareholders, employees, and agents, hereby irrevocably and unconditionally
forever releases and discharges Levin and all of his successors, assigns, and legal representatives of the foregoing (which, together
with Levin collectively are referred to as the “Levin Releasees”) of and from, any matter or thing occurring
in whole or in part through the date hereof, any and all Claims which the Company has asserted, could assert or which could be
asserted on its behalf arising from Levin’s relationship to, employment with or service as an employee, officer, director,
or manager of the Company or its subsidiaries and affiliates prior to the date of execution and delivery of this Agreement, including
Levin’s employment and separation therefrom; provided, however, that the Company does not release any claim that the Company
may have for indemnification pursuant to any indemnification agreement between Levin and the Company or otherwise existing pursuant
to the Company’s organizational documents or applicable state law, except insofar as such Claim is released by this Agreement,
including its release and discharge of Levin from any and all Claims whatsoever up to the date hereof that it had, may have had,
now have or may have for or by reason of any claim arising out of or attributable to Levin’s relationship to, employment
with or service as an employee, officer, director, manager, agent, lessor, sublessor, licensor, sublicensor or vendor of the Company
or its subsidiaries and affiliates, or pursuant to any, United States federal, state, or local law or regulation. The Company agrees
to indemnify and hold the Levin Releasees harmless from and against any Claim, grievance, loss, damage, liability, cost or expense,
including without limitation, reasonable attorneys’ fees, by reason of the Company’s breach of this Agreement, including
the representations, warranties, and covenants made under this Agreement.

 

    	 

    	 

    

 

(c) Levin warrants
and represents that he has not heretofore assigned or transferred to any person or entity any of the matters released hereunder,
nor has he filed any grievance, charge or complaints against Company with any governmental or administrative agency or court. Levin
agrees to indemnify and hold the Releasees harmless from and against any Claims, including without limitation, reasonable attorneys’
fees by reason of Levin's breach of this Agreement, including the representations, warranties, and covenants made under this Agreement.

 

(d)The Parties acknowledge
that this Agreement is an important legal document and that each of them has been requested to sign this document in connection
with Levin’s separation from the Company. The Parties acknowledge that each of them: (i) has read this Agreement in its entirety,
(ii) is competent to execute this Agreement, (iii) has executed this Agreement knowingly and voluntarily and without reliance upon
any statement or representation of any Releasee or Levin Releasee (as the case may be) or any of its respective representatives
(other than those statements and representations expressly included in this Agreement), (iv) has been advised to, and has had ample
opportunity if so desired to, discuss this Agreement with his or its own attorney for assistance and advice concerning this Agreement,
(v) understands that the terms of this Agreement have been negotiated, (vi) understands the terms of this Agreement and their legal
effects, and (vii) understands that the terms of this Agreement are enforceable. Levin further covenants, warrants, and represents
that he has entered into this Agreement freely and voluntarily.

 

(e)The Parties further
agree without any reservation whatsoever that neither of them shall sue the other Party or voluntarily become a party to a lawsuit
on the basis of any and all Claims of any type lawfully and validly released herein.

 

    	 

    	 

    

 

(f)Levin hereby waives
any right to monetary recovery or individual relief should any federal, state, or local agency (including the Equal Employment
Opportunity Commission) pursue any claim on Levin’s behalf arising out of or related to Levin’s employment with and/or
separation from employment with the Company.

 

(g)Notwithstanding
anything in this Agreement to the contrary, the covenants, agreements and obligations under this Section 3 shall become effective
only upon the receipt by Levin of a scanned copy of (i) the physical certificate evidencing the Shares (as defined below); and
(ii) an irrevocable instruction from the Company to its Transfer Agent instructing the Transfer Agent to deliver the certificate
evidencing the Shares to Levin as provided for in Section 6 hereof.

 

4.                 
Termination; Severance. The Parties hereby agree that the Employment Agreement (except for Section 11 thereof, which
survives and continues in effect in accordance with this Agreement) is being terminated hereunder by mutual agreement of the Parties.
The Parties hereby acknowledge and agree that the payments required to be made pursuant to Section 7.4 of the Employment Agreement
and otherwise in accordance with the Employment Agreement shall be revised as follows:

 

(a)               
Not later than two (2) business days following the Separation Date, (i) Levin shall be paid his unpaid Base Salary (as that
term is defined and used in the Employment Agreement) through and including the Separation Date, minus all applicable withholding
taxes in accordance with normal payroll withholding practices, and (ii) Levin shall be reimbursed for all reasonable travel and
other business expenses incurred by Levin in the performance of his duties under the Employment Agreement through the Separation
Date for which Levin has submitted a reimbursement form with applicable receipts attached.

 

(b)              
The Parties acknowledge and agree that there are no “earned and accrued but unpaid bonuses” as described in
clause (iv) of Section 7.4 of the Employment Agreement; and

 

(c)               
The Company shall not be obligated to make any of the payments required by the third sentence of Section 7.4 of the Employment
Agreement.

 

5.                 
Cash Payment. The Company shall pay Levin a lump sum payment of $8,583.00, representing the payment for health insurance
required by Section 7.4 of the Employment Agreement.

 

6.                 
Grant and Vesting of Restricted Stock. Promptly after the execution of this Agreement, the Company shall issue to
Levin, in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”),
an aggregate of 375,000 fully vested shares (the “Shares”) of common stock, par value $0.01 per share,
of the Company, and the Company shall instruct the Company’s transfer agent to deliver to Levin physical stock certificates
evidencing the Shares to Levin at Merrill Lynch, 200 South Biscayne Blvd., Miami, Florida 33131, c/o Adam Rosenfeld. The Parties
agree that Levin’s entry into this Agreement, including the provisions of Section 3 hereof, shall be deemed adequate consideration
for issuance of the Shares under the Maryland General Corporation Law and that, upon the issuance of the Shares to Levin, such
Shares will be duly authorized, fully paid and nonassessable. Levin acknowledges and agrees that that the certificates representing
the Shares to be issued and delivered to Levin shall bear (i) the legend regarding restrictions on ownership and transfer under
Section 6.10 of the Company’s Articles of Restatement (as imprinted on all certificates evidencing issued and outstanding
shares of Common Stock), and (ii) the following legend:

 

    	 

    	 

    

 

THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT’), OR THE SECURITIES LAWS OF ANY STATE, AND MAY NOT BE SOLD EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF RULE 144 UNDER
THE SECURITIES ACT AND AT SUCH TIME AS THE TRANSFER RESTRICTIONS OF RULE 144 CEASE TO APPLY TO SUCH SALES. 

 

7.                  Securities
Act Compliance. In connection with the issuance and receipt of the Shares pursuant to Section 6 of this Agreement,
Levin represents and warrants to the Company that:

 

(a)               
The Shares are being acquired for Levin’s own account, for the purpose of investment and not with a view to or for
sale in connection with any public resale or distribution thereof in violation of applicable securities laws;

 

(b)              
Levin is an “accredited investor” within the meaning of Rule 501(a) promulgated under the Securities Act and
is knowledgeable, sophisticated and experienced in business and financial matters, and Levin fully understands the limitations
on ownership, sale, transfer or other disposition of the Shares;

 

(c)               
Levin understands that the Shares may be resold only if registered pursuant to the provisions of the Securities Act or
if an exemption from registration is available, except under circumstances where neither such registration nor such an exemption
is required by law; and

 

(d)              
Levin understands and agrees that the Shares are being offered in a transaction not involving any public offering within
the meaning of the Securities Act, that such shares have not been registered under the Securities Act and that such shares may
be offered, resold, pledged or otherwise transferred only (i) in a transaction not involving a public offering, (ii) pursuant
to an exemption from registration under the Securities Act, including, without limitation, the exemption provided by Rule 144
thereunder (if available), (iii) pursuant to an effective registration statement under the Securities Act or (iv) to the Company,
in each of cases (i) through (iv) in accordance with any applicable state and federal securities laws;

 

(e)               
Levin understands and agrees that the Company’s issuance of the Shares is being made in reliance on Levin’s
representations in this Section 7.

 

    	 

    	 

    

 

8.                 Rule
144. The Company agrees to use its reasonable best efforts to file all reports and other documents required to be
filed by it under the Securities Exchange Act of 1934, as amended, and the rules and regulations adopted by the Securities
and Exchange Commission thereunder (or, if the Company is not required to file such reports, it will, upon the request of
Levin, make publicly available such information as may be necessary to permit sales pursuant to Rule 144 of the Securities
Act), and will use its reasonable best efforts to take such further action as Levin may reasonably request, at the sole
expense of Levin, all to the extent required from time to time to enable Levin to sell the Shares without registration under
the Securities Act consistent with the exemptions provided by Rule 144 of the Securities Act.

 

9.                
No Admission. The Parties agree that this Agreement does not constitute an admission by the Company or Levin of any:
(i) violation of any statute, law, regulation, order or other applicable authority; (ii) breach of contract, actual or implied;
or (iii) commission of any tort.

 

10.             
Non-Disparagement. Each of the Parties hereto agrees not to disparage the other or the other’s officers, directors,
employees, attorneys, agents, consultants or representatives (or, in the case of the Company, any of its products or services);
provided, that the foregoing shall not prohibit Levin or the Company from making any general competitive statements or communications
about the other or their businesses in the ordinary course of competition. Further, Levin agrees and understands that any material
violation of this provision will void this Agreement and Levin will be required to return or repay to the Company any and all consideration
received under this Agreement.

 

11.             
Confidentiality. The Parties hereto agree to keep the existence and terms of this Agreement and the circumstances
of Levin’s separation from the Company confidential, except as required to be disclosed by the regulations of the Securities
and Exchange Commission or the listing rules of the NASDAQ Global Market. Levin specifically agrees not to discuss the existence
or terms of this Agreement with any third party except for his spouse, legal counsel and financial and legal advisors. Levin acknowledges
that during the course of Levin’s employment he has had access to and/or the Company has disclosed to him information relating
to the nature and operation of the Company’s business, the Company’s manner of operation, its financial condition,
its business operations, it business and marketing plans, legal matters and pricing methods (hereinafter “Confidential
Information”). Levin agrees that, for a period of one year from the date this Agreement is executed, Levin will retain
in confidence such Confidential Information and that Levin will not, either directly or indirectly, use, misappropriate, reveal,
disclose, publish, communicate or divulge any such Confidential Information to any other person or entity for any purpose whatsoever
except as required by law or pursuant to section 13, below. Levin expressly agrees that he shall keep secret and confidential all
such Confidential Information, except as authorized by the Company in writing or as required by law or pursuant to Section 13,
below.

 

12.             
Non-Competition. Effective upon the execution of this Agreement, the Company agrees that the provisions of Section
10.1 of Levin’s Employment Agreement shall no longer have any force or effect and that Levin shall not be subject to any
restriction on his ability to compete with the Company.

 

    	 

    	 

    

 

13.             
Cooperation. After the Separation Date, Levin agrees to make himself available, upon reasonable request, to the Company,
its external and internal auditors, and representatives for the purpose of providing information and cooperating with respect to
pending or future investigations, audits, and inquiries on matters in which Levin was involved during his tenure as President of
the Company and/or about which Levin has knowledge.

 

14.             
Binding Effect. All terms and provisions of this Agreement, whether so expressed or not, shall be binding upon, inure
to the benefit of, and be enforceable by the Parties and their respective administrators, executors, other legal representatives,
heirs, successors and permitted assigns.

 

15.             
Enforcement Costs. If any legal action or other proceeding is brought for the enforcement of this Agreement, or because
of an alleged dispute, breach, default or misrepresentation in connection with any provisions of this Agreement, the successful
or prevailing Party or Parties shall be entitled to recover reasonable attorneys' fees and expenses, court costs and all expenses
even if not taxable as court costs (including, but not limited to, all attorneys' fees and expenses incident to any appeals), incurred
in that action or proceeding, in addition to any other relief to which such Party or Parties may be entitled.

 

16.             
Entire Agreement. This Agreement (together with the agreements and documents expressly referenced herein) represents
the entire understanding and Agreement between the Parties with respect to the subject matter discussed in this Agreement, and
supersedes all other negotiations, understandings and representations (if any) made by and between such Parties with respect to
such subject matter. In the event that any provision in this Agreement is determined to be legally invalid or unenforceable by
any court of competent jurisdiction and cannot be modified to be enforceable, the affected provision shall be stricken from the
Agreement, and the remaining terms of the Agreement and its enforceability shall remain unaffected thereby.

 

17.             
Counterparts. This Agreement may be executed in one or more counterparts, and counterparts may be exchanged by electronic
transmission (including by email), each of which will be deemed an original, but all of which together constitute one and the same
instrument.

 

18.             
Opportunity for Independent Representation. Levin hereby acknowledges and agrees that he has been given the opportunity,
if so desired, to seek independent counsel for review and advice in connection with his rights, remedies and obligations under
this Agreement.

 

19.             
Governing Venue and Submission to Jurisdiction. This Agreement shall be governed by the laws of the State of Maryland.
Any suit, action or other legal proceeding arising out of, or relating to, this Agreement shall be brought in a court of competent
jurisdiction located in Baltimore, Maryland having subject matter jurisdiction thereof and both Parties agree to submit to the
jurisdiction of such forum.

 

    	 

    	 

    

 

20.             
 Notices. All notices, demands, requests and replies required or permitted by this Agreement shall be in writing
and shall be deemed given when delivered in person or on the third (3rd) business day following the date of mailing if sent by
first-class mail, postage prepaid, return receipt requested, addressed as follows:

 

		(a)	if to the Company:

 

Trade Street Residential, Inc.

Attention: Richard Ross

19950 W. Country Club Drive

Suite 800

Aventura, FL 33180

 

		(b)	if to Levin:

 

David Levin

121 Camden Drive

Bal Harbor, FL 33154

 

PLEASE READ CAREFULLY. THIS DOCUMENT INCLUDES A RELEASE OF
ALL KNOWN AND UNKNOWN CLAIMS.

 

[Signature Page Follows]

 

    	 

    	 

    

 

The undersigned, Levin,
hereby represents that he has executed this Agreement for the purposes and the consideration expressed herein, and that he has
carefully read this Agreement, has had adequate time and opportunity to consider and understand its meaning and effect, and, if
he so desired, discussed it with any person of his choice, including his attorney, and that he has voluntarily executed it as such.

 

The undersigned Parties,
intending to be legally bound, have executed this Agreement as of the day and year first above written.

 

	 	LEVIN: 
	 	 	 
	 	/s/ David Levin
	 	David Levin
	 	 	 
	 	TRADE STREET RESIDENTIAL, INC.
	 	 	 
	 	By: 	/s/ Richard Ross
	 	Name:   	Richard Ross
	 	Title: 	Chief Executive Officer and Financial OfficerMarch 13, 2014

 

GenVec, Inc.

65 West Watkins Mill Road

Gaithersburg, MD 20878

 

Ladies and Gentlemen:

 

The undersigned (the “Investor”)
hereby confirms and agrees with you as follows:

 

1.           This
Purchase Agreement (the “Agreement”) is made as of the date hereof between GenVec, Inc., a Delaware corporation (the
“Company”), and the Investor that is a signatory to this Agreement.

 

2.           The
Company has authorized the sale and issuance (the “Offering”) of up to 2,870,000 shares of its common stock (the “Offered
Securities”), par value $0.001 per share (the “Common Stock”).  The Offering is being made pursuant to an
effective shelf registration statement on Form S-3 (SEC File No. 333-193511).

 

3.           The
Company and the Investor agree that the Offering is being made subject to the execution by the Company and the Placement Agents
of the Placement Agency Agreement, delivery of the base prospectus and a preliminary prospectus supplement relating to the Offered
Securities and delivery of additional offering information, including pricing information.  The Company and the Investor
agree that the Investor will purchase from the Company and the Company will issue and sell to the Investor the number of Offered
Securities set forth below the Investor’s name on Schedule I hereto, at a purchase price of $3.15 per share, pursuant to
the Terms and Conditions for Purchase of Offered Securities attached hereto as Annex I and incorporated herein by reference
as if fully set forth herein.  The Investor acknowledges that the Offering is not being underwritten by the Placement
Agents and that there is no minimum offering amount.  Shares of Common Stock will be credited to the Investor using customary
book-entry procedures.

 

4.           The
Investor represents that, except as set forth below, (a) it has had no position, office or other material relationship within the
past three years with the Company or persons known to it to be affiliates of the Company, (b) neither it, nor any group of which
it is a member or to which it is related, beneficially owns (including the right to acquire or vote) more than 19.9% of any class
of securities of the Company and (c) it is not a FINRA member as of the date hereof.

 

5.           The
Investor confirms that it has had full access to all filings made by the Company with the Securities and Exchange Commission, including
the registration statement and base prospectus relating to the Offered Securities, and the documents incorporated by reference
therein, and that it was able to read, review, download and print each such filing.

 

    	 

    	 

    

 

Please confirm that the foregoing correctly
sets forth the agreement between us by signing in the space provided below for that purpose.

 

	 	Name of Investor:	 	 
	 	 	 	 
	 	 	 	By:	 
	 	 	 	 	 
	 	 	 	Name:	 
	 	 	 	 	 
	 	 	 	Title:	 

 

AGREED AND ACCEPTED:

 

GENVEC, INC.

 

	By:	 	 
	 	 	 
	Name:	 	 
	 	 	 
	Title:	 	 

 

    	 

    	 

    

 

SCHEDULE I

 

SCHEDULE OF INVESTORS

	Name of Investor:
	 
	_________________________________
	 
	Name of Individual Representing

Investor:
	 
	_________________________________
	 
	Title of Individual Representing

Investor:
	 
	_________________________________

 

	Address:	 	 
	 	 	 
	Telephone:	 	 
	 	 	 
	Telecopier:	 	 

 

	
        Number of Offered 

        Securities to Be 

        Purchased
	
        Price Per Share In 

        Dollars
	
        Aggregate 

        Purchase Price

	 	$3.15	$

 

    	 

    	 

    

 

ANNEX I

 

TERMS AND CONDITIONS FOR PURCHASE OF
OFFERED SECURITIES

 

1.           Agreement
to Sell and Purchase the Offered Securities; Placement Agents.

 

1.1         Upon
the terms and subject to the conditions hereinafter set forth, at the Closing (as defined in Section 2 below), the Company will
sell to the Investor, and the Investor will purchase from the Company, the number of shares of Common Stock set forth on Schedule
I of this Agreement below such Investor’s name at the purchase price set forth therein.

 

1.2         
The Company may enter into agreements similar to this Agreement with certain other investors (the “Other Investors”)
and expects to complete sales of Offered Securities to them. (The Investor and the Other Investors hereinafter collectively are
referred to as the “Investors,” and this Agreement and the agreements executed by the Other Investors are hereinafter
collectively referred to as the “Agreements”). The Company may accept or reject any one or more Agreements in its sole
discretion.

 

1.3           The
Company has entered into a Placement Agency Agreement (the “Placement Agency Agreement”) dated the date hereof with
Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC in their capacities as Placement Agents for the Offering (together,
the “Placement Agents”), and the Company has agreed to pay the Placement Agents a fee in respect of the sale of the
Common Stock.

 

2.           Delivery
of the Shares at Closing.  The completion of the purchase and sale of the Offered Securities (the “Closing”)
shall take place at a place and time (the “Closing Date”) to be specified by the Company and the Placement Agents,
in accordance with Rule 15c6-1 promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

  The Company’s obligation to
issue and sell the Offered Securities at Closing to the Investor shall be subject to the accuracy of the representations and warranties
made by the Investor and the fulfillment of those undertakings of the Investor to be fulfilled prior to the Closing.

 

  The Investor’s obligation to
purchase the Offered Securities shall be subject to the condition that the Placement Agents shall not have (a) terminated the Placement
Agency Agreement pursuant to the terms thereof or (b) determined that the conditions to closing in the Placement Agency Agreement
have not been satisfied.

 

The manner of settlement of the Offered Securities
purchased by the Investor shall be determined by such Investor as follows (check one):

 

[          ]
A.     [____]   A.     Delivery by crediting the account of the Investor’s prime broker (as specified by such Investor on
Exhibit A annexed hereto) with the Depository Trust Company (“DTC”) through its Deposit/Withdrawal At Custodian (“DWAC”)
system, whereby Investor’s prime broker shall initiate a DWAC transaction on the Closing Date using its DTC participant identification
number, and released by American Stock Transfer & Trust Company, the Company’s transfer agent (the “Transfer Agent”),
at the Company’s direction. NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR AND
THE COMPANY, THE INVESTOR SHALL:

 

		(I)	DIRECT THE BROKER-DEALER AT WHICH THE ACCOUNT OR ACCOUNTS TO BE CREDITED WITH THE SHARES ARE MAINTAINED TO SET UP A DWAC INSTRUCTING
THE TRANSFER AGENT TO CREDIT SUCH ACCOUNT OR ACCOUNTS WITH THE SHARES, AND

 

    	 

    	 

    

 

		(II)	REMIT BY WIRE TRANSFER THE AMOUNT OF FUNDS EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE OFFERED SECURITIES BEING PURCHASED
BY THE INVESTOR TO THE FOLLOWING ACCOUNT:

 

[To be separately provided to the Investor]

—OR—

 

[____]    B.    Delivery Versus
Payment (“DVP”) through DTC (i.e., on the Closing Date, the Company shall issue the Offered Securities registered
in the Investor’s name and address as set forth below and released by the Transfer Agent directly to the account(s) at Roth
Capital Partners, LLC (“Roth”) identified by the Investor; upon receipt of such Offered Securities, Roth shall
promptly electronically deliver such Offered Securities to the Investor, and simultaneously therewith payment shall be made by
Roth by wire transfer to the Company). NO LATER THAN ONE (1) BUSINESS DAY AFTER THE EXECUTION OF THIS AGREEMENT BY THE INVESTOR
AND THE COMPANY, THE INVESTOR SHALL:

 

		(III)	NOTIFY ROTH OF THE ACCOUNT OR ACCOUNTS AT ROTH TO BE CREDITED WITH THE SHARES BEING PURCHASED BY SUCH INVESTOR, AND

 

		(IV)	CONFIRM THAT THE ACCOUNT OR ACCOUNTS AT ROTH TO BE CREDITED WITH THE SHARES BEING PURCHASED BY THE INVESTOR HAVE A MINIMUM
BALANCE EQUAL TO THE AGGREGATE PURCHASE PRICE FOR THE UNITS BEING PURCHASED BY THE INVESTOR.

 

IT IS THE INVESTOR’S RESPONSIBILITY
TO (A) MAKE THE NECESSARY WIRE TRANSFER OR CONFIRM THE PROPER ACCOUNT BALANCE IN A TIMELY MANNER AND (B) ARRANGE FOR SETTLEMENT
BY WAY OF DWAC OR DVP IN A TIMELY MANNER. IF THE INVESTOR DOES NOT DELIVER THE AGGREGATE PURCHASE PRICE FOR THE OFFERED SECURITIES
OR DOES NOT MAKE PROPER ARRANGEMENTS FOR SETTLEMENT IN A TIMELY MANNER, THE OFFERED SECURITIES MAY NOT BE DELIVERED AT CLOSING
TO THE INVESTOR OR THE INVESTOR MAY BE EXCLUDED FROM THE CLOSING ALTOGETHER.

 

3.           Representations,
Warranties and Covenants of the Company.  The Company hereby represents and warrants to, and covenants with, the
Investor, as follows:

 

3.1         The
issuance and sale of each of the Offered Securities have been duly authorized by the Company, and the Offered Securities, when
issued and paid for in accordance with this Agreement, will be duly and validly issued, fully paid and nonassessable and will not
be subject to preemptive or similar rights.

 

3.2         This
Agreement constitutes a valid and binding obligation of the Company enforceable against the Company in accordance with its terms,
subject to the effect of applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally and equitable
principles of general applicability.

 

3.3         The
Company shall not effect any offer or sale of any equity or equity-related securities that would result in the transactions contemplated
hereby becoming subject to stockholder approval under the rules and regulations of FINRA or the NASDAQ Global Market.

 

3.4         It
is understood and acknowledged by the Company that: (i) except pursuant to the terms of this Agreement and any confidentiality
agreement entered into by the Investor with respect to the transactions contemplated hereby, the Investor has not been asked by
the Company to agree, nor has the Investor agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or “derivative” securities based on securities issued by the Company or to hold the Offered Securities for any specified
term; (ii) past or future open market or other transactions by the Investor, specifically including, without limitation, Short
Sales or “derivative” transactions, before or after the closing of this or future private placement transactions, may
negatively impact the market price of the Company’s publicly-traded securities; (iii) the Investor, and counter-parties in
“derivative” transactions to which the Investor is a party, directly or indirectly, presently may have a “short”
position in the Common Stock, and (iv) the Investor shall not be deemed to have any affiliation with or control over any arm’s
length counter-party in any “derivative” transaction merely by reason of such “derivative” transaction.
The Company further understands and acknowledges that (y) subject to the terms of this Agreement and any confidentiality agreement
entered into by the Investor with respect to the transactions contemplated hereby, the Investor may engage in hedging activities
at various times during the period that the Offered Securities are outstanding, and (z) such hedging activities (if any) could
reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities
are being conducted.

 

    	 

    	 

    

 

3.5         The
Company will use its commercially reasonable efforts to maintain the effectiveness of the registration statement through the Closing
in accordance with the rules and regulations promulgated by the Securities and Exchange Commission.

 

3.6         Prior
to 9:30 a.m., New York City time, on March 13, 2014, the Company will issue a press release (the “Press Release”) via
BusinessWire (or other national wire service) announcing the transaction contemplated by this Agreement. In connection with the
transactions contemplated by this Agreement, the Company has not disclosed, or caused to be disclosed, to the Investor any material
non-public information regarding the Company that will not at the time of the issuance of the Press Release be in the public domain.

 

4.           Representations,
Warranties and Covenants of the Investor.  The Investor represents and warrants to the Company as follows:

 

4.1         The
Investor has received the Company’s base prospectus and a preliminary prospectus supplement relating to the Offered Securities
describing the terms of the proposed Offering.  The Investor acknowledges that the Investor has received certain additional
information regarding the Offering, including pricing information (the “Offering Information”). Such Offering Information
may be provided to the Investor by any means permitted under the Securities Act of 1933, as amended, including through a prospectus
supplement, a free writing prospectus and oral communications.

 

4.2         The
Investor has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated
hereby and has taken all necessary action to authorize the execution, delivery and performance of this Agreement, and this Agreement
constitutes a valid and binding obligation of the Investor enforceable against the Investor in accordance with its terms, subject
to the effect of applicable bankruptcy, insolvency or similar laws affecting creditors’ rights generally and equitable principles
of general applicability.

 

4.3         The
Investor is knowledgeable, sophisticated and experienced in making, and is qualified to make, decisions with respect to investments
in shares representing an investment decision like that involved in the purchase of the Offered Securities and has, in connection
with its decision to purchase the number of Offered Securities set forth on Schedule I to the Agreement, relied solely upon the
registration statement, the base prospectus, the preliminary term sheet, the Offering Information and any amendments or supplements
thereto and has not relied upon any information provided by the Placement Agents.

 

4.4         The
Investor understands that nothing in the registration statement, the base prospectus, the preliminary term sheet, the Offering
Information and any amendments or supplements thereto, this Agreement or any other materials presented to such Investor in connection
with the purchase and sale of the Offered Securities constitutes legal, tax or investment advice.  The Investor has consulted
such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its
purchase of Offered Securities.

 

4.5         The
Investor will not, upon the Closing of the transactions contemplated by this Agreement, beneficially own, as calculated in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended, in excess of, 19.99% of the shares of Common Stock outstanding.

 

4.6         From
and after obtaining knowledge of the sale of the Offered Securities contemplated hereby, the Investor has not engaged in any purchases
or sales of the securities of the Company (including, without limitation, any Short Sales (as defined herein) involving the Company’s
securities), and has not violated its obligations of confidentiality.  The Investor covenants that it will not engage in any
purchases or sales of the securities of the Company (including Short Sales) or disclose any information about the contemplated
offering (other than to its advisors that are under a legal obligation of confidentiality) prior to the time that the transactions
contemplated by this Agreement are publicly disclosed.  The Investor agrees that it will not use any of the Units acquired
pursuant to this Agreement to cover any short position in the Common Stock if doing so would be in violation of applicable securities
laws.  For purposes hereof, “Short Sales” include, without limitation, all “short sales” as defined
in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and
indirect stock pledges, forward sales contracts, options, puts, calls, short sales, swaps, “put equivalent positions”
(as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and sales and
other transactions through non-US broker dealers or foreign regulated brokers.

 

    	 

    	 

    

 

5.           Survival
of Representations, Warranties and Agreements.  Notwithstanding any investigation made by any party to this Agreement,
all covenants, agreements, representations and warranties made by the Company and the Investor herein shall survive the execution
of this Agreement, the delivery to such Investor of the Offered Securities being purchased and the payment therefor.

 

6.           Notices.  All
notices, requests, consents and other communications hereunder shall be in writing, shall be mailed (A) if within domestic United
States, by first-class registered or certified airmail, or nationally recognized overnight express courier, postage prepaid, or
by facsimile, or (B) if delivered from outside the United States, by International Federal Express or facsimile, and shall be deemed
given (i) if delivered by first-class registered or certified mail domestic, three business days after so mailed, (ii) if delivered
by a nationally recognized overnight carrier, one business day after so mailed, (iii) if delivered by International Federal Express,
two business days after so mailed, (iv) if delivered by facsimile, upon electronic confirmation of receipt and shall be delivered
as addressed as follows: (a) if to the Company, at the office of the Company, 65 West Watkins Mill Road, Gaithersburg, MD  20878,
fax: 301.944.1902, Attention: Douglas J. Swirsky, with copies to Hogan Lovells US LLP, 100 International Drive, Suite 2000, Baltimore,
MD 21202, fax: 410.659.2701, Attention: Asher M. Rubin and William I. Intner; and (b) if to an Investor, at its address on
Schedule I hereto, or at such other address or addresses as may have been furnished to the Company in writing by such Investor.

 

7.           Changes.  This
Agreement may not be modified or amended except pursuant to an instrument in writing signed by the Company and the Investor.

 

8.           Headings.  The
headings of the various sections of this Agreement have been inserted for convenience or reference only and shall not be deemed
to be part of this Agreement.

 

9.           Severability.  In
case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality
and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby.

 

10.         Governing
Law.  This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of New
York, without giving effect to the principles of conflicts of law.

 

11.         Counterparts;
Facsimile.  This Agreement may be executed in two or more counterparts, each of which shall constitute an original,
but all of which, when taken together, shall constitute one instrument, and shall become effective when one or more counterparts
have been signed by each party hereto and delivered to the other parties.  Facsimile signatures shall be as effective
as original signatures.

 

    	 

    	 

    

 

Annex
II

 

GENVEC, INC.

 

INVESTOR QUESTIONNAIRE

 

Pursuant to Annex I to the Agreement,
please provide us with the following information:

 

	1. The exact name that your Offered Securities are to be registered in. You may use a nominee name if appropriate:	 	 
	 	 	 
	2. The relationship between the Investor and the registered holder listed in response to item 1 above:	 	 
	 	 	 
	3. The mailing address of the registered holder listed in response to item 1 above:	 	 
	 	 	 
	4. The Social Security Number or Tax Identification Number of the registered holder listed in the response to item 1 above:	 	 
	 	 	 
	5. Name of DTC Participant (broker-dealer at which the account or accounts to be credited with the Shares are maintained):	 	 
	 	 	 
	6. DTC Participant Number:	 	 
	 	 	 
	7. Name of Account at DTC Participant being credited with the Offered Securities:	 	 
	 	 	 
	8. Account Number at DTC Participant being credited with the Offered Securities:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00228-of-00352.parquet"}]]